425: CoreWeave Details Proposed Acquisition of Core Scientific, Highlights Transaction Risks and Future Filings

CoreWeave, Inc. has filed a Form 425 communication regarding its proposed acquisition of Core Scientific, Inc., emphasizing the need for investors to review forthcoming SEC filings detailing the transaction and associated risks.

Summary

• CoreWeave, Inc. is pursuing a proposed acquisition of Core Scientific, Inc.
• The communication is a Form 425 filing, stemming from a blog post by CoreWeave CEO Michael Intrator on July 7, 2025.
• CoreWeave and Core Scientific will file a registration statement on Form S-4, which will include a proxy statement/prospectus, with the SEC.
• Investors and security holders are strongly urged to read the Form S-4, proxy statement/prospectus, and other relevant SEC filings carefully before making any voting or investment decisions.
• The document clarifies that it is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities or a solicitation of any vote or approval.
• Extensive forward-looking statements are included, highlighting uncertainties and risks associated with the transaction and future business performance.
• Information regarding participants in the proxy solicitation (directors and executive officers of both companies) is referenced in prior SEC filings.

Sentiment

Score: 6

Explanation: The document is a formal disclosure of a proposed acquisition, outlining the process and extensive risks. While the underlying event (acquisition) can be positive, the tone is cautious due to the detailed risk factors and forward-looking statement disclaimers, leading to a neutral-to-slightly-positive sentiment.

Positives

• The proposed transaction aims for the successful integration of businesses and the achievement of anticipated synergies and value creation.

Negatives

• Disruptions from the proposed transaction may harm CoreWeave's or Core Scientific's business, including current plans and operations.
• Management's time and attention will be diverted to transaction-related issues during the pendency of the proposed acquisition.

Risks

• Completion of the proposed transaction on anticipated terms, or at all, and the timing of completion, including obtaining required regulatory approvals and Core Scientific stockholder approval.
• Unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, and future prospects.
• The possibility that anticipated benefits of the proposed transaction will not be realized or will not be realized within the expected time period.
• The ability of CoreWeave and Core Scientific to integrate their businesses successfully and to achieve anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction that could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Rating agency actions and CoreWeave's and Core Scientific's ability to access shortand long-term debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Changes in local, national, or international laws, regulations, and policies affecting CoreWeave and Core Scientific.
• Potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the proposed transaction.
• Certain restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue certain business opportunities or strategic transactions.
• Acts of terrorism or outbreak of war, hostilities, civil unrest, attacks against CoreWeave or Core Scientific, and other political or security disturbances.
• The possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events.
• The impacts of pandemics or other public health crises, including the effects of government responses on people and economies.
• Global or regional changes in the supply and demand for power and other market or economic conditions that impact demand and pricing.
• Changes in technical or operating conditions, including unforeseen technical difficulties.
• Development delays at CoreWeave and/or Core Scientific data center sites, including any delays in the conversion of such sites from crypto mining facilities to high-performance computing sites.

Future Outlook

Forward-looking statements address future business and financial events, conditions, expectations, plans, or ambitions, including the consummation of the proposed transaction and its anticipated benefits. These statements are based on current plans, estimates, and expectations, but are subject to significant risks, uncertainties, and assumptions that could cause actual results to differ materially. Neither CoreWeave nor Core Scientific assumes any obligation to publicly update these statements unless required by law.

Management Comments

• Michael Intrator, Chief Executive Officer of CoreWeave, Inc., posted a blog on CoreWeave's website on July 7, 2025, in connection with the proposed acquisition of Core Scientific, Inc.

Industry Context

This proposed acquisition signifies a strategic move within the data center industry, particularly highlighting the convergence or transition from traditional crypto mining operations (Core Scientific) towards high-performance computing and artificial intelligence infrastructure (CoreWeave). It reflects a broader industry trend where existing data center capacity, including those previously optimized for cryptocurrency mining, are being repurposed or acquired to meet the surging demand for AI and HPC capabilities.

Legal Proceedings

• Potential litigation relating to the proposed transaction could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.

Stakeholder Impact

• Shareholders of Core Scientific will be required to vote on the proposed transaction.
• CoreWeave shareholders may experience dilution due to the issuance of additional shares in connection with the transaction.
• Employees of both companies may be impacted by the integration of businesses.
• Customers and suppliers may experience changes to business relationships due to the announcement or completion of the proposed transaction.

Next Steps

• CoreWeave and Core Scientific will file a registration statement on Form S-4 with the SEC, which will include a proxy statement of Core Scientific and a prospectus of CoreWeave.
• A definitive proxy statement/prospectus will be mailed to stockholders of Core Scientific.
• Core Scientific stockholder approval for the proposed transaction is required.
• Regulatory approvals may be required for the completion of the transaction.

Key Dates

Keywords

CoreWeave, Core Scientific, Acquisition, Merger, SEC Filing, Form 425, Form S-4, Proxy Statement, Prospectus, Artificial Intelligence, High-Performance Computing, Data Center, Crypto Mining, Corporate Governance, Risk Factors